Characterization of pathways involved in colorectal cancer using real-time RT-PCR gene expression data
Gastroenterology and Hepatology from Bed to Bench,
Vol. 14 No. 2 (2021),
8 Esfand 2021
,
Page 123-131
https://doi.org/10.22037/ghfbb.v14i2.1928
Abstract
Aim: Efforts to explore biomarkers and biological pathways involved in the disease are needed to improve colorectal cancer (CRC) diagnosis and alternative treatments
Background: The fourth common malignancy in the world is colorectal cancer. The over-all burden is predicted to rise by 2030.
Methods: In the current study, nine genes were selected. Previously, a panel of genes by Agendia, a classifier of robust gene expression (ColoPrint), was determined to significantly improve the prognostic accuracy of pathologic factors in stage II and III colorectal cancer patients. Five genes, including Ppara, Mctp1, Pyroxd1, Il2r, and Cyfip2, from this panel and four other genes which were not in this panel but were cited abundantly in the literature were selected. Then, expression levels of the selected genes in CRC tissue were compared with levels in adjacent normal tissue. To identify the pathways involved in CRC, gene set enrichment analysis was subsequently performed. Furthermore, to illustrate the relationship between genes in this disease, the cross-shaped co-expression pattern and gene regulatory network were determined using computational methods.
Results: This research found that the pairs of genes: {IL2R, CYFIP2}, {FOXM1, PPARA}, {MCTP1, CTSC}, and {PYROXD1, CYF1P2} are functionally related. Furthermore, two differentially expressed gene pairs ({FOXM1, PPARA} and {IL2R, CYFIP2}) are involved in the vascular endothelial growth factor receptor signaling pathway and the purine ribonucleoside diphosphate metabolic process, respectively.
Conclusion: This research found that the combination of computational analysis and laboratory data provided the opportunity to better characterize the relation between central colorectal cancer genes as well as possible pathways involved in the colorectal cancer.
Keywords: Colorectal cancer, Computational analysis, Real-time RT-PCR, Gene set enrichment analysis (GSEA), Gene regulatory network (GRN).
(Please cite as: Shabani S, Khayer N, Motalebzade J, Majidi zadeh T, Mahjoubi F. Characterization of pathways involved in colorectal cancer using real-time RT-PCR gene expression data. Gastroenterol Hepatol Bed Bench 2021;14(2):123-131).
- bioinformatics
- bioinformatics analysis
- genetics
- colon cancer
- Gene set enrichment analysis (GSEA))
- gene regulatory network (GRN)
How to Cite
References
Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Prev Biomarkers 2009;18:1688-94.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136.
Williams NS, Gaynor RB, Scoggin S, Verma U, Gokaslan T, Simmang C, et al. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 2003;9:931-46.
Distaso A, Abatangelo L, Maglietta R, Creanza TM, Piepoli A, Carella M, et al. Biological and functional analysis of statistically significant pathways deregulated in colon cancer by using gene expression profiles. Int J Biol Sci 2008;4:368.
Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science-New York Then Washington 1995:467-67.
DeRisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997;278:680-86.
Azuaje F. A cluster validity framework for genome expression data. Bioinformatics 2002;18:319-20.
Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, Biasco G. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treatment Rev 2009;35:201-09
Sim E, Bong I, Balraj P, Tan S, Jamal R, Sagap I, et al. A preliminary study of differentially expressed genes in Malaysian colorectal carcinoma cases. J Biosci 2006;17:19-37
Kitahara O, Furukawa Y, Tanaka T, Kihara C, Ono K, Yanagawa R, Nita ME, Takagi T, Nakamura Y, Tsunoda T. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 2001;61:3544-49.
Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001;61:3124-30.
Storey J, Tibshirani R. Statistical significance for genomewide studies Proc Natl Acad Sci USA Find this article online 2003;100:9440-5.
Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847.
Li KC. Genome-wide coexpression dynamics: theory and application. Proc Natl Acad Sci U S A 2002;99:16875-80.
Rao CV, Arkin AP. Control motifs for intracellular regulatory networks. Annu Rev Biomed Eng 2001;3:391-419.
Maak M, Simon I, Nitsche U, Roepman P, Snel M, Glas AM, et al. Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer. Annals of surgery 2013;257:1053-58.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 2005;102:15545-50.
Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009;25:1091-3.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-504
Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behavioural Brain Res 2001;125:279-84.
Remo A, Simeone I, Pancione M, Parcesepe P, Finetti P, Cerulo L, et al. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer. J Transl Med 2015;13:138.
Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, Dalla Favera R, et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC bioinformatics 2006;7:S7.
Floratos A, Smith K, Ji Z, Watkinson J, Califano A. geWorkbench: an open source platform for integrative genomics. Bioinformatics 2010;26:1779-80.
Fukushima A. DiffCorr: an R package to analyze and visualize differential correlations in biological networks. Gene 2013;518:209-14.
Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. Cancer J Clin 2020;70:145-64.
Katenkamp D. Histological classification of soft tissue tumors and staging according to the TNM system. Der Pathol 2011;32:8-13.
Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, Cantor A, et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 2005;23:3526-35.
Wooi CS, Hang ESU. Overexpression of Wildtype Periostin and Transforming Growth Factor Beta I Genes in Colorectal Carcinoma: A Preliminary Study. Pertanika J Trop Agric Sci 20072009. p. 153-59.
Khayer N, Marashi S-A, Mirzaie M, Goshadrou F. Three-way interaction model to trace the mechanisms involved in Alzheimer’s disease transgenic mice. PloS one 2017;12:e0184697.
Khayer N, Mirzaie M, Marashi SA, Jalessi M. Rps27a might act as a controller of microglia activation in triggering neurodegenerative diseases. Plos one 2020;15:e0239219.
Kalin TV, Ustiyan V, Kalinichenko VV. Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models. Cell Cycle 2011;10:396-405.
Huang C, Du J, Xie K. FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis. Biochim Biophys Acta Rev Cancer 2014;1845:104-16.
Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 2009;69:9090-95.
Khayer N, Mirzaie M, Marashi SA, Rezaei-Tavirani M, Goshadrou F. Three-way interaction model with switching mechanism as an effective strategy for tracing functionally-related genes. Exp Rev Proteomics 2019;16:161-69.
Fukushima A. DiffCorr: an R package to analyze and visualize differential correlations in biological networks. Gene 2013;518:209-14.
Alsina M, Ruiz-Echarri M, Capdevila J, Muñoz E, Tabernero J. Biomarkers for therapies directed at angiogenesis. Curr Colorectal Cancer Rep 2010;6:133-43.
Giles FJ. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies. The Oncol 2001;6:32-9.
Stacker SA, Achen MG. The VEGF signaling pathway in cancer: the road ahead. Chinese J Cancer 2013;32:297.
Bergers G, Benjamin LE. Angiogenesis: tumorigenesis and the angiogenic switch. Nature Rev Cancer 2003;3:401.
Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005;23:1011-27.
Lam EWF, Brosens JJ, Gomes AR, Koo CY. Forkhead box proteins: tuning forks for transcriptional harmony. Nature Rev Cancer 2013;13:482-95
Ustiyan V, Wang IC, Ren X, Zhang Y, Snyder J, Xu Y, et al. Forkhead box M1 transcriptional factor is required for smooth muscle cells during embryonic development of blood vessels and esophagus. Develop Biol 2009;336:266-79.
Zhang Y, Zhang N, Dai B, Liu M, Sawaya R, Xie K, et al. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res 2008;68:8733-42.
Michalik L, Desvergne B, Wahli W. Peroxisome-proliferator-activated receptors and cancers: complex stories. Nature Rev Cancer 2004;4:61-70.
Berger E, Vega N, Vidal H, Geloën A. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival. Biotechnol J 2012;7:1395-404.
Pollak N, Dölle C, Ziegler M. The power to reduce: pyridine nucleotides–small molecules with a multitude of functions. Biochemical J 2007;402:205-18.
- Abstract Viewed: 36 times
- PDF Downloaded: 29 times